Article Text

An experimental inactivated vaccine against bluetongue
  1. J Parker,
  2. KA Herniman,
  3. EP Gibbs and
  4. RF Sellers


Bluetongue virus grown in BHK cells was shown to be inactivated in concentrations of betapropiolactone (BPL) higher than 0-15 per cent. When the virus, inactivated with 0-2 per cent BPL and prepared as a double emulsion vaccine, was injected into Cypriot sheep, no untoward reactions were observed and neutralising antibodies developed. The antibody titre reached a high level and persisted for at least a year. After re-vaccination, a secondary response was observed. A bivalent vaccine elicited a response to both virus types incorporated. The possibilities of using a polyvalent inactivated vaccine are discussed.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.